Join Sandoz, Sanofi, Boehringer Ingelheim, Italfarmaco S.p.A., Mundipharma and more at Biosimilars and Biobetters
This year's two-day conference programme will cover regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access and global market developments.
- (1888PressRelease) August 21, 2015 - SMi's 6th annual Biosimilars and Biobetters conference, taking place on 30th September - 1st October 2015 in London, will provide the ideal platform to engage in scientific discussions and debate the best practices and solutions to improve industry performance through technical case studies and practical advice from leading biosimilar and regulatory players.
The packed agenda features 16 case study driven presentations, an interactive panel debate plus over 3 hours of valuable networking sessions:
16 case studies from leading industry players including Merck Serono, Teva, Cinfa Biotech GmbH, MHRA and many more
Interactive panel debate to assess the sustainability of Biosimilars and Biobetters market in Europe
2 workshops on regulatory developments and understanding commerciality
3hrs+ networking time with 70+ selected Biosimilars/Biobetters leaders
Network with a global audience of leading scientists and key decision makers in the Biosimilars and Biobetters arena. Confirmed attendees include: AbbVie, Alston & Bird LLP, Anteris Medical GmbH, Arnold & Porter LLP, Boehringer Ingelheim, Bristows LLP, Cinfa Biotech GmbH, Ecole Normale Supιrieure de Cachan, Eppendorf, Fresenius Kabi, GfK, Grifols, Harvest Moon Pharmaceuticals, IMS Health UK, Italfarmaco S.p.A., Kantar Health, Kinesys Consulting, Merck Serono, MHRA, Mundipharma, Norwegian Medicines Agency, SAI MedPartners, Sandoz International GmbH, Sanofi, Selecta Biosciences, SGS Life Science Services, SGS M-Scan Ltd, Teva, University of Basel, Venner Shipley LLP plus many more...
Featured speakers include:
Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals USA, Inc.
Shahin Kauser, Senior Scientific Assessor, MHRA
Chris Teale, Vice President Europe, GfK NOP Ltd
Bracha Timan, Director, Israel Site Head, Global Bioassays & Technology, Global R&D, Teva
Takashi Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences
Karsten Roth, Director Clinical Operations, Cinfa Biotech GmbH
Alan Sheppard, Principal, Global Generics and Biosimilars, IMS Health
Steinar Madsen, Medical Director, Norwegian Medicines Agency
To view the full speaker line-up and conference programme, visit http://www.biosimilars-biobetters.co.uk/1888pressrelease
Plus, don't miss two interactive conference workshops on:
Assessing the Regulatory Framework for Europe and the US - Developing Future Biologics
Workshop Leaders: Lincoln Tsung, Daniel Kracov, Jennifer Sklenar, Partners, Arnold & Porter (UK) LLP | 1:00pm - 5.30pm, 29th September 2015
Biosimilars - Understanding the Regulatory Processes and the Commercial Realities
Workshop Leader: Peter Wittner, Senior Consultant, Interpharm Consultancy | 8:30am - 12.30pm, 2nd October 2015
###
space
space
Contact Information
- Vinh Trinh
- Smi Group
- Unit 122/124 Great Guildford Business Square, 30 Great Guildford Street, London
- SE1 0BS
- Voice: 44 (0) 20 7827 6140
- Visit our Site
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam